Pyrvinium pamoate inhibits cell proliferation through ROS-mediated AKT-dependent signaling pathway in colorectal cancer
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
The use of the anthelmintic drug pyrvinium pamoate (PP) in cancer therapy has been extensively investigated in the last decade. PP has been shown to have an inhibitory effect in colorectal cancer (CRC), but the underlying mechanism remains elusive. We aimed to investigate the antitumor activity and mechanisms of PP in CRC. In the present study, we used CCK-8 assays, colony formation assays, and western blotting to reveal that PP effectively suppressed CRC cell proliferation and the AKT-dependent signaling pathway in a concentration-dependent and time-dependent manner. Flow cytometric analysis and fluorescence microscopy demonstrated that PP increased intracellular reactive oxygen species (ROS) accumulation. We found that the inhibitory effect of PP on cell proliferation and AKT protein expression induced by PP could be partially reversed by N-acetyl-l-cysteine (NAC), an ROS scavenger. In addition, the results also demonstrated that PP inhibited cell migration by modulating epithelial-to-mesenchymal transition (EMT)-related proteins, including E-cadherin and vimentin. In conclusion, our data suggested that PP effectively inhibited cell proliferation through the ROS-mediated AKT-dependent signaling pathway in CRC, further providing evidence for the use of PP as an antitumor agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our findings together with those of others who showed that PP induced cytotoxicity in PDAC cells while sparing nonmalignant human pancreatic epithelial cells suggest that it is selective for PDAC cells and may therefore be associated with limited side effects [31, 32, 33].”
From Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models (2024) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084 · cited 1×
“Reactive oxygen species (ROS) are mainly produced in mitochondria during cell metabolism [7].”
BackgroundDekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32319-0 · Cited by 4,974
Cancer treatment and survivorship statistics, 2019
Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21565 · Cited by 4,226 · cited 1×
“Nonetheless, CRC still ranks as the third most fatal cancer globally, and a large proportion of patients have a poor quality of life due to multiple dysfunctions caused by treatments [1, 3].”
BackgroundReactive oxygen species, cellular redox systems, and apoptosis
Circu, M. L., & Aw, T. Y. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.12.022 · Cited by 3,340 · cited 1×
“At low concentrations, ROS play an effective role in intracellular signal transduction and cellular function regulation [8].”
BackgroundPI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,443 · cited 1×
“Previous research has shown that the AKT signaling pathway is involved in a variety of biological processes, including growth, proliferation, and apoptosis [32, 33].”
BackgroundROS stress in cancer cells and therapeutic implications
Pelicano, H., Carney, D., & Huang, P. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.01.004 · Cited by 2,006 · cited 2×
“However, excessive increases in ROS levels destroy cellular DNA and gene stability [9].”
BackgroundROS signalling in the biology of cancer
Moloney, J. N., & Cotter, T. G. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.05.023 · Cited by 1,970
Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals
Prasad, S., Gupta, S. C., & Tyagi, A. K. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.03.042 · Cited by 978 · cited 2×
“Endogenous ROS are mainly produced as a byproduct of mitochondrial respiration [27].”
BackgroundSuperoxide dismutase as a target for the selective killing of cancer cells
Huang, P., Feng, L., Oldham, E. A., Keating, M. J., & Plunkett, W. (2000) · Nature · doi:10.1038/35030140 · Cited by 842 · cited 2×
“However, when ROS levels exceed the cellular antioxidant capacity, they contribute to cell damage [13].”
BackgroundTargeted therapies: a new generation of cancer treatments.
Gerber, D. E. (2008) · PubMed · Cited by 637
EMT and inflammation: inseparable actors of cancer progression
Suarez‐Carmona, M., Lesage, J., Cataldo, D., & Gilles, C. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12095 · Cited by 566 · cited 1×
“The EMT plays a major role in increasing cell invasiveness, stem-like features, and resistance to apoptosis, which makes tumors more aggressive [38].”
BackgroundOxidative stress induces degradation of mitochondrial DNA
Shokolenko, I., Venediktova, N., Bochkareva, A., Wilson, G. L., & Alexeyev, M. F. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp100 · Cited by 549 · cited 1×
“However, the overproduction of ROS in turn leads to mitochondrial DNA double-strand breakage and degradation [35].”
BackgroundInhibition of Mitochondrial Respiration
Pelicano, H., Feng, L., Zhou, Y., Carew, J. S., Hileman, E. O., Plunkett, W., Keating, M. J., & Huang, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301546200 · Cited by 495
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Thorne, C. A., Hanson, A. J., Schneider, J., Tahinci, E., Orton, D., Cselenyi, C. S., Jernigan, K. K., Meyers, K. C., Hang, B. I., Waterson, A. G., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.453 · Cited by 485 · cited 1×
“As an inhibitor of Wnt signaling, PP significantly suppressed β-catenin expression and decreased cell growth by activating casein kinase 1α [19].”
BackgroundRole of EMT in Metastasis and Therapy Resistance
Smith, B., & Bhowmick, N. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020017 · Cited by 484 · cited 1×
“It has conclusively been shown that tumor invasion, migration, and metastasis are associated with epithelial-to-mesenchymal transition (EMT) progression in multiple solid tumors [21].”
BackgroundLamb, R., Ozsvari, B., Lisanti, C. L., Tanowitz, H. B., Howell, A., Martinez-Outschoorn, U. E., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.3174 · Cited by 478 · cited 2×
“In addition, cancer stem cells (CSCs) have been reported to be the targets of the anticancer effects of PP. PP inhibited mitochondrial oxidative phosphorylation, which is essential for the survival and growth of CSCs [25, 26].”
BackgroundNovellasdemunt, L., Antas, P., & Li, V. S. W. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00117.2015 · Cited by 339 · cited 1×
“On the other hand, Wnt signaling promotes the initiation and progression of CRC by causing mutations in adenomatous polyposis coli (APC) and β-catenin [18].”
BackgroundChemotherapy induced DNA damage response: Convergence of drugs and pathways
Woods, D., & Turchi, J. J. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23761 · Cited by 296
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana
Kazusa DNA Research Institute, The Cold Spring Harbor and Washington University Sequencing Consortium, The European Union Arabidopsis Genome Sequencing Consortium, & Institute of Plant Genetics and Crop Plant Research (IPK) (2000) · Nature · doi:10.1038/35048507 · Cited by 230
Adolescent and young adult oncology—past, present, and future
Close, A. G., Dreyzin, A., Miller, K. D., Seynnaeve, B. K. N., & Rapkin, L. B. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21585 · Cited by 225
Lamb, R., Harrison, H., Hulit, J., Smith, D. L., Lisanti, M. P., & Sotgia, F. (2014) · Oncotarget · doi:10.18632/oncotarget.2789 · Cited by 190 · cited 2×
“In addition, cancer stem cells (CSCs) have been reported to be the targets of the anticancer effects of PP. PP inhibited mitochondrial oxidative phosphorylation, which is essential for the survival and growth of CSCs [25, 26].”
BackgroundReactive oxygen species and colorectal cancer
Lin, S., Li, Y., Zamyatnin, A. A., Werner, J., & Bazhin, A. V. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26356 · Cited by 164 · cited 2×
“Therefore, cancer treatments targeting ROS may result in fewer side effects for patients [11].”
BackgroundLamb, R., Bonuccelli, G., Ozsvári, B., Peiris-Pagès, M., Fiorillo, M., Smith, D. L., Bevilacqua, G., Mazzanti, C. M., McDonnell, L. A., Naccarato, A. G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5852 · Cited by 145
Esumi, H., Lu, J., Kurashima, Y., & Hanaoka, T. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03330.x · Cited by 127 · cited 2×
“showed that PP inhibits cancer cell proliferation and viability during glucose starvation [17].”
BackgroundYang, J., LI, T. Z., XU, G. H., Luo, B., Chen, Y. X., & ZHANG, T. (2013) · Neoplasma · doi:10.4149/neo_2013_048 · Cited by 118 · cited 1×
“At a low concentration, capsaicin induces ROS accumulation and promotes CRC metastasis by regulating the AKT/mTOR and STAT-3 pathways [37].”
BackgroundBetulinic Acid Induces Apoptosis in Differentiated PC12 Cells Via ROS-Mediated Mitochondrial Pathway
Wang, X., Lu, X., Zhu, R., Zhang, K., Li, S., Chen, Z., & Li, L. (2017) · Neurochemical Research · doi:10.1007/s11064-016-2147-y · Cited by 109 · cited 1×
“A previous study has shown that increased ROS levels occur in the early stage of apoptosis, followed by the loss of mitochondrial membrane potential [31].”
BackgroundHussain, A. R., Shahab Uddin, M. S., Bu, R., Khan, O. S., Ahmed, S. O., Ahmed, M., & Al-Kuraya, K. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024703 · Cited by 93 · cited 1×
“ROS-mediated activation of AKT can inhibit cell viability and induce apoptosis [14, 15].”
BackgroundYogosawa, S., Yamada, Y., Yasuda, S., Sun, Q., Takizawa, K., & Sakai, T. (2012) · Journal of Natural Products · doi:10.1021/np300465f · Cited by 81 · cited 1×
“A number of studies have explored the antitumor effects of small molecules that modulate ROS in CRC [29, 30].”
BackgroundROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells
Chetram, M. A., Bethea, D. A., Odero-Marah, V., Don-Salu-Hewage, A. S., Jones, K. J., & Hinton, C. V. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1549-7 · Cited by 77 · cited 1×
“ROS-mediated activation of AKT can inhibit cell viability and induce apoptosis [14, 15].”
BackgroundThe novel role of pyrvinium in cancer therapy
Momtazi‐borojeni, A. A., Abdollahi, E., Ghasemi, F., Caraglia, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26006 · Cited by 75 · cited 3×
“Pyrvinium pamoate (PP) is a classic anthelmintic drug that has been suggested to be a potential agent for cancer therapy in recent years [16].”
BackgroundInfluentialArsenite induces cell transformation by reactive oxygen species, AKT, ERK1/2, and p70S6K1
Carpenter, R. L., Jiang, Y., Jing, Y., He, J., Rojanasakul, Y., Liu, L.-Z., & Jiang, B. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.102 · Cited by 74 · cited 1×
“A previous study has indicated that arsenic-induced cell transformation through ROS mediates the activation of AKT, ERK1/2, and P70S6K1 [36].”
BackgroundThe immunomodulatory role of probiotics in allergy therapy
Hajavi, J., Esmaeili, S., Varasteh, A., Vazini, H., Atabati, H., Mardani, F., Momtazi‐Borojeni, A. A., Hashemi, M., Sankian, M., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27263 · Cited by 64
Yuan, J., Ji, H., Xiao, F., Lin, Z., Zhao, X., Wang, Z., Zhao, J., & Lu, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.102 · Cited by 60
Lipid quantification by Raman microspectroscopy as a potential biomarker in prostate cancer
O’Malley, J., Kumar, R., Kuzmin, A. N., Pliss, A., Yadav, N., Balachandar, S., Wang, J., Attwood, K. M., Prasad, P. N., & Chandra, D. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.025 · Cited by 58
Guo, J., Lv, J., Chang, S., Chen, Z., Lu, W., Xu, C., Liu, M., & Pang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9932 · Cited by 53 · cited 2×
“The growth of bladder tumors in mice 1 3 Medical Oncology (2021) 38:21 1 3 Page 7 of 9 21 could be suppressed by PP by blocking the cytoplasmic accumulation of HuR [24].”
BackgroundFetal Microchimeric Cells in Blood of Women with an Autoimmune Thyroid Disease
Lepez, T., Vandewoestyne, M., Hussain, S., Nieuwerburgh, F. V., Poppe, K. G., Velkeniers, B., Kaufman, J., & Deforce, D. L. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029646 · Cited by 50
The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer
Xu, W., Lacerda, L., Debeb, B. G., Atkinson, R. L., Solley, T. N., Li, L., Orton, D., McMurray, J. S., Hang, B. I., Lee, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071508 · Cited by 47 · cited 1×
“PP can also delay tumor growth in pancreatic and breast cancer animal models [17, 23].”
BackgroundCarrella, D., Manni, I., Tumaini, B., Dattilo, R., Papaccio, F., Mutarelli, M., Sirci, F., Amoreo, C. A., Mottolese, M., Iezzi, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11318 · Cited by 47 · cited 4×
“PP has also been shown to be an inhibitor of the PI3K-dependent signaling pathway, as it effectively suppresses downstream target molecules of PI3K, including AKT and P70S6K [20].”
BackgroundInfluentialXiao, M., Zhang, L., Zhou, Y., Rajoria, P., & Wang, C. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.12.059 · Cited by 41 · cited 1×
“Additionally, PP has a critical role in suppressing mitochondrial respiration and respiratory complex I activity, leading to elevated ROS and decreased ATP levels [34].”
BackgroundAl‐Khayal, K., Alafeefy, A. M., Vaali‐Mohammed, M., Mahmood, A., Zubaidi, A. M., Al-Obeed, O. A., Khan, Z., Abdulla, M., & Ahmad, R. (2017) · BMC Cancer · doi:10.1186/s12885-016-3005-7 · Cited by 38 · cited 1×
“A number of studies have explored the antitumor effects of small molecules that modulate ROS in CRC [29, 30].”
BackgroundThe impact of pyrvinium pamoate on colon cancer cell viability
Wiegering, A., Uthe, F.-W., Hüttenrauch, M., Mühling, B., Linnebacher, M., Krummenast, F., Germer, C.-T., Thalheimer, A., & Otto, C. (2014) · International Journal of Colorectal Disease · doi:10.1007/s00384-014-1975-y · Cited by 37 · cited 1×
“The combination of PP and 5-fluorouracil has a synergistic effect on the inhibition of CRC cell proliferation [22].”
BackgroundTang, L., Guo-lin, C., & Xu, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082806 · Cited by 35
Liu, Y., Shi, Q.-F., Ye, Y., Tashiro, S., Onodera, S., & Ikejima, T. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12048fp · Cited by 32 · cited 1×
“showed that ROS accumulate in the mitochondria of tumor cells and promote cell proliferation, cell survival, cell migration, and epithelial-mesenchymal transition [28].”
BackgroundErdreich‐Epstein, A., Singh, A. R., Joshi, S., Vega, F. M. D. L., Guo, P., Xu, J., Groshen, S. G., Ye, W., Millard, M., Campan, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13386 · Cited by 30
Packard, T. A., Smith, M. J., Conrad, F., Johnson, S. A., Getahun, A., Lindsay, R. S., Hinman, R. M., Friedman, R. S., Thomas, J. W., & Cambier, J. C. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5110098 · Cited by 22
Li, T., Luo, Z., Liu, Y., Wang, M., Yu, X., Cao, C., Liao, Z., Ding, Y., & Yue, S. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2451-1 · Cited by 21
The role Hiwi gene in the maintenance of lung cancer stem cell populations
Liang, D., Yang, Y., & Liu, Y. (2013) · Neoplasma · doi:10.4149/neo_2014_022 · Cited by 18
Niu, M., Sun, Y., Liu, X., Tang, L., & Qiu, R. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12206fp · Cited by 15
de Souza, L. R., Muehlmann, L. A., Matos, L. C., Simón‐Vázquez, R., Lacava, Z. G. M., de Paula, A. M. B., Mosiniewicz-Szablewska, E., Suchocki, P., Morais, P. C., González‐Fernández, Á., et al. (2015) · Nanotechnology · doi:10.1088/0957-4484/26/50/505101 · Cited by 12 · cited 1×
“Therefore, several lines of research on small molecule antitumor agents with reduced toxicity have been investigated in the last few decades [6].”
Background
Cited by
The Role of Oxidative Stress in Tumorigenesis and Progression
Li, K., Deng, Z., Lei, C., Ding, X., Li, J., & Wang, C. (2024) · Cells · doi:10.3390/cells13050441 · Cited by 153
“It was found that high levels of ROS mediated AKT-dependent signaling pathways to effectively inhibit the proliferation of rectal cancer (CRC) cells [51].”
BackgroundOxidative Stress and Inflammation: Drivers of Tumorigenesis and Therapeutic Opportunities
Wang, M., Xiao, Y., Miao, J., Zhang, X., Liu, M., Zhu, L., Liu, H., Shen, X., Wang, J., Xie, B., et al. (2025) · Antioxidants · doi:10.3390/antiox14060735 · Cited by 129
Chen, Y., Chen, M., & Deng, K. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5472 · Cited by 67
Wu, J., Wang, D., Zhou, J., Li, J., Xie, R., Li, Y., Huang, J., Liu, B., & Qiu, J. (2022) · Phytotherapy Research · doi:10.1002/ptr.7614 · Cited by 48
“Excessive ROS leads to cell damage and apoptosis by destroying cellular DNA and gene stability (Zheng et al., 2021).”
BackgroundPyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug
Schultz, C. W., & Nevler, A. (2022) · Biomedicines · doi:10.3390/biomedicines10123249 · Cited by 44
“In addition to pre-clinical studies assessing PP as a monotherapy in colon cancer [50,72], PP was found to act as a chemoprotective agent in the formation of intestinal polyps in an APCmin mouse model, presumably through its inhibition of the WNT pathway [47].”
Background
Metadata
- Authors
- Zheng, W., Hu, J., Lv, Y., Bai, B., Shan, L., Chen, K., Dai, S., & Zhu, H.
- Affiliations
- Sir Run Run Shaw Hospital (CN)
- Corresponding author
- Zhu, Hongbo
- Venue
- Medical Oncology
- Published
- 2021-02
- Volume
- 38
- Issue
- 2
- Pages
- 21-21
- ISSN
- 1357-0560 (ISSN-L)
- 1559-131X
- PMC
- PMC7868320
- OpenAlex
- W3127161950
- Cited by
- 21
- References
- 52
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 5 · 2022: 4
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor, 7 d)
- Locations
- Medical Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81272681)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- pyrvinium pamoate, colorectal cancer, reactive oxygen species, Akt signaling, cell proliferation inhibition, anthelmintic repurposing, N-acetylcysteine, epithelial-mesenchymal transition, E-cadherin, vimentin, cell migration
- MeSH terms
- Cell Movement, Cell Survival, Humans, Pyrvinium Compounds, Colorectal Neoplasms, Signal Transduction, Reactive Oxygen Species, Cell Line, Tumor, Cell Proliferation, Proto-Oncogene Proteins c-akt, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.